JP2006513202A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006513202A5 JP2006513202A5 JP2004563361A JP2004563361A JP2006513202A5 JP 2006513202 A5 JP2006513202 A5 JP 2006513202A5 JP 2004563361 A JP2004563361 A JP 2004563361A JP 2004563361 A JP2004563361 A JP 2004563361A JP 2006513202 A5 JP2006513202 A5 JP 2006513202A5
- Authority
- JP
- Japan
- Prior art keywords
- group
- compound according
- optionally substituted
- compound
- aminocarbonyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 44
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 9
- 125000000623 heterocyclic group Chemical group 0.000 claims 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 8
- 239000002525 vasculotropin inhibitor Substances 0.000 claims 8
- -1 aralkoxy group Chemical group 0.000 claims 6
- 239000000203 mixture Substances 0.000 claims 6
- 230000001154 acute effect Effects 0.000 claims 5
- 125000003342 alkenyl group Chemical group 0.000 claims 5
- 125000003118 aryl group Chemical group 0.000 claims 5
- 208000002780 macular degeneration Diseases 0.000 claims 5
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 5
- 125000000547 substituted alkyl group Chemical group 0.000 claims 5
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 4
- 125000003710 aryl alkyl group Chemical group 0.000 claims 4
- 125000004181 carboxyalkyl group Chemical group 0.000 claims 4
- 125000000753 cycloalkyl group Chemical group 0.000 claims 4
- 125000003107 substituted aryl group Chemical group 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 3
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 3
- 125000003545 alkoxy group Chemical group 0.000 claims 3
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 125000004414 alkyl thio group Chemical group 0.000 claims 3
- 125000004659 aryl alkyl thio group Chemical group 0.000 claims 3
- 125000004104 aryloxy group Chemical group 0.000 claims 3
- 230000001404 mediated effect Effects 0.000 claims 3
- LELOWRISYMNNSU-UHFFFAOYSA-N Hydrocyanic acid Chemical group N#C LELOWRISYMNNSU-UHFFFAOYSA-N 0.000 claims 2
- 125000003282 alkyl amino group Chemical group 0.000 claims 2
- 125000003277 amino group Chemical group 0.000 claims 2
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 claims 2
- 125000004093 cyano group Chemical group *C#N 0.000 claims 2
- 125000004663 dialkyl amino group Chemical group 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 2
- ZQGVXCZSHVLLNA-UHFFFAOYSA-N 2-[1-(1-benzofuran-2-carbonyl)piperidin-4-yl]-n-(5-carbamoyl-2-methoxyphenyl)-1,3-thiazole-4-carboxamide Chemical compound COC1=CC=C(C(N)=O)C=C1NC(=O)C1=CSC(C2CCN(CC2)C(=O)C=2OC3=CC=CC=C3C=2)=N1 ZQGVXCZSHVLLNA-UHFFFAOYSA-N 0.000 claims 1
- 201000009273 Endometriosis Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 125000002947 alkylene group Chemical group 0.000 claims 1
- 125000000304 alkynyl group Chemical group 0.000 claims 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 claims 1
- 238000003745 diagnosis Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 125000002541 furyl group Chemical group 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- RKRNGWLHGHJULB-UHFFFAOYSA-N n-(5-carbamoyl-2-methoxyphenyl)-2-[1-(4,7-dimethylpyrazolo[5,1-c][1,2,4]triazine-3-carbonyl)piperidin-4-yl]-1,3-thiazole-4-carboxamide Chemical compound COC1=CC=C(C(N)=O)C=C1NC(=O)C1=CSC(C2CCN(CC2)C(=O)C2=C(N3N=C(C)C=C3N=N2)C)=N1 RKRNGWLHGHJULB-UHFFFAOYSA-N 0.000 claims 1
- GNYSPFJSQCPIQD-UHFFFAOYSA-N n-(5-carbamoyl-2-methoxyphenyl)-2-[1-[2-(2-chlorophenyl)acetyl]piperidin-4-yl]-1,3-thiazole-4-carboxamide Chemical compound COC1=CC=C(C(N)=O)C=C1NC(=O)C1=CSC(C2CCN(CC2)C(=O)CC=2C(=CC=CC=2)Cl)=N1 GNYSPFJSQCPIQD-UHFFFAOYSA-N 0.000 claims 1
- JITDERODDZHJOA-UHFFFAOYSA-N n-(5-carbamoyl-2-methoxyphenyl)-2-[1-[2-(3,4-dimethylphenoxy)acetyl]piperidin-4-yl]-1,3-thiazole-4-carboxamide Chemical compound COC1=CC=C(C(N)=O)C=C1NC(=O)C1=CSC(C2CCN(CC2)C(=O)COC=2C=C(C)C(C)=CC=2)=N1 JITDERODDZHJOA-UHFFFAOYSA-N 0.000 claims 1
- HKZCWJKZGLEYBZ-UHFFFAOYSA-N n-(5-carbamoyl-2-methoxyphenyl)-2-[1-[[4-(dimethylamino)phenyl]carbamothioyl]piperidin-4-yl]-1,3-thiazole-4-carboxamide Chemical compound COC1=CC=C(C(N)=O)C=C1NC(=O)C1=CSC(C2CCN(CC2)C(=S)NC=2C=CC(=CC=2)N(C)C)=N1 HKZCWJKZGLEYBZ-UHFFFAOYSA-N 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0230162.0A GB0230162D0 (en) | 2002-12-24 | 2002-12-24 | Compounds useful in inhibiting angiogenesis |
| PCT/GB2003/005651 WO2004058750A1 (en) | 2002-12-24 | 2003-12-24 | Piperidinyl-thiazole carboxylic acid derivatives as angiogenesis inhibitors |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006513202A JP2006513202A (ja) | 2006-04-20 |
| JP2006513202A5 true JP2006513202A5 (https=) | 2007-02-08 |
Family
ID=9950429
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2004563361A Pending JP2006513202A (ja) | 2002-12-24 | 2003-12-24 | 血管形成インヒビターとしてのピペリジニル−チアゾールカルボン酸誘導体 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20060135501A1 (https=) |
| EP (1) | EP1581528B1 (https=) |
| JP (1) | JP2006513202A (https=) |
| AT (1) | ATE368662T1 (https=) |
| AU (2) | AU2003290335A1 (https=) |
| CA (1) | CA2511506A1 (https=) |
| DE (1) | DE60315355T2 (https=) |
| GB (1) | GB0230162D0 (https=) |
| WO (2) | WO2004058750A1 (https=) |
Families Citing this family (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2856685B1 (fr) * | 2003-06-25 | 2005-09-23 | Merck Sante Sas | Derives de thiazolylpiperidine, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent |
| WO2005116653A2 (en) * | 2004-04-13 | 2005-12-08 | Arena Pharmaceuticals, Inc. | Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| EP1637529A1 (en) | 2004-09-20 | 2006-03-22 | 4Sc Ag | Novel piperidin-4-yl-thiazole-carboxamide analogues as inhibitors of T-cell proliferation and uses thereof |
| WO2006032322A1 (en) * | 2004-09-20 | 2006-03-30 | 4Sc Ag | NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| US7601745B2 (en) | 2004-09-27 | 2009-10-13 | 4Sc Ag | Heterocyclic NF-kB inhibitors |
| TW200738701A (en) | 2005-07-26 | 2007-10-16 | Du Pont | Fungicidal carboxamides |
| WO2007016979A2 (en) * | 2005-07-29 | 2007-02-15 | 4Sc Ag | NOVEL HETEROCYCLIC NF-κB INHIBITORS |
| GB0518494D0 (en) * | 2005-09-09 | 2005-10-19 | Argenta Discovery Ltd | Thiazole compounds |
| EP1832586A1 (en) * | 2006-03-10 | 2007-09-12 | Oridis Biomed Forschungs- und Entwicklungs GmbH | Thiazole-piperidine derivatives in treatment of diseases of liver and the pancreas |
| EP1832585A1 (en) * | 2006-03-10 | 2007-09-12 | ORIDIS BIOMED Forschungs- und Entwicklungs GmbH | Thiazole-piperidine derivatives for treatment of hyperproliferative diseases |
| EP1834954A1 (en) * | 2006-03-15 | 2007-09-19 | 4Sc Ag | Thiazoles as NF-kB Inhibitors (proteasome inhibitors) |
| EP1994017A2 (en) * | 2006-03-15 | 2008-11-26 | 4Sc Ag | Novel heterocyclic nf-kb inhibitors |
| EA200801838A1 (ru) * | 2006-03-15 | 2009-02-27 | 4ЭсЦэ АГ | НОВЫЕ ГЕТЕРОЦИКЛИЧЕСКИЕ ИНГИБИТОРЫ NF-kB |
| US9090604B2 (en) | 2006-07-27 | 2015-07-28 | E I Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| WO2008013622A2 (en) * | 2006-07-27 | 2008-01-31 | E. I. Du Pont De Nemours And Company | Fungicidal azocyclic amides |
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| JP5337711B2 (ja) * | 2007-01-25 | 2013-11-06 | イー・アイ・デュポン・ドウ・ヌムール・アンド・カンパニー | 殺菌性アミド |
| AU2008279447A1 (en) | 2007-07-19 | 2009-01-29 | Metabolex, Inc. | N-azacyclic substituted pyrrole, pyrazole, imidazole, triazole and tetrazole derivatives as agonists of the RUP3 or GPR119 receptor for the treatment of diabetes and metabolic disorders |
| WO2009018844A1 (en) * | 2007-08-09 | 2009-02-12 | Oridis Biomed Forschungs- Und Entwicklungs Gmbh | Thiazole-piperidine derivatives for treatment of hyperproliferative diseases |
| DE102007047735A1 (de) | 2007-10-05 | 2009-04-09 | Merck Patent Gmbh | Thiazolderivate |
| TWI428091B (zh) | 2007-10-23 | 2014-03-01 | Du Pont | 殺真菌劑混合物 |
| EP2070925A1 (de) * | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Neue 2-substituierte Tiazol-4-carbonsäureamid-Derivative deren Herstellung und Verwendung als Arzneimittel |
| EP2070924A1 (de) * | 2007-12-10 | 2009-06-17 | Bayer Schering Pharma Aktiengesellschaft | Neue 2-Hetarylthiazol-4-carbonsäureamid-Derivative, deren Herstellung und Verwendung als Arzneimittel |
| EP2238133A2 (en) * | 2008-01-25 | 2010-10-13 | E. I. du Pont de Nemours and Company | Fungicidal amides |
| US8349870B2 (en) * | 2008-01-25 | 2013-01-08 | E I Du Pont De Nemours And Company | Fungicidal hetercyclic compounds |
| BRPI0910837B1 (pt) | 2008-04-30 | 2017-03-07 | Bayer Cropscience Ag | ésteres e tioésteres tiazol-4-carboxílicos, seus usos, e método e composição para controlar fungos fitopatogênicos prejudiciais |
| EP2334669B1 (de) * | 2008-10-01 | 2015-12-23 | Bayer Intellectual Property GmbH | Heterocyclyl substituierte thiazole als pflanzenschutzmittel |
| US20110160222A1 (en) * | 2008-11-26 | 2011-06-30 | Metabolex, Inc. | Modulators of glucose homeostasis for the treatment of diabetes and metabolic disorders |
| AU2009322486A1 (en) | 2008-12-02 | 2010-06-10 | E. I. Du Pont De Nemours And Company | Fungicidal heterocyclic compounds |
| WO2010108503A1 (en) | 2009-03-24 | 2010-09-30 | Life & Brain Gmbh | Promotion of neuronal integration in neural stem cell grafts |
| US8410127B2 (en) * | 2009-10-01 | 2013-04-02 | Metabolex, Inc. | Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts |
| WO2011051243A1 (en) | 2009-10-29 | 2011-05-05 | Bayer Cropscience Ag | Active compound combinations |
| KR20120101019A (ko) | 2009-10-30 | 2012-09-12 | 바이엘 크롭사이언스 아게 | 헤테로아릴피페리딘 및 -피페라진 유도체 |
| BR112012027762B1 (pt) * | 2010-04-28 | 2018-06-05 | Bayer Intellectual Property Gmbh | Derivados de cetoheteroarilpiperidina e - piperazina como fungicidas |
| US8815775B2 (en) * | 2010-05-18 | 2014-08-26 | Bayer Cropscience Ag | Bis(difluoromethyl)pyrazoles as fungicides |
| CN109674753A (zh) | 2010-06-23 | 2019-04-26 | 希玛贝治疗股份有限公司 | 固态分散体 |
| WO2012104273A1 (de) * | 2011-02-01 | 2012-08-09 | Bayer Cropscience Ag | Heteroarylpiperidin und -piperazinderivate als fungizide |
| AU2017305392A1 (en) | 2016-08-03 | 2019-02-21 | Cymabay Therapeutics, Inc. | Oxymethylene aryl compounds for treating inflammatory gastrointestinal diseases or gastrointestinal conditions |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3966748A (en) * | 1975-05-08 | 1976-06-29 | American Cyanamid Company | Para-fluorophenyl-N-heterocyclic substituted butanes |
| GB9410534D0 (en) * | 1994-05-26 | 1994-07-13 | Lynxvale Ltd | Improvements in or relating to growth factor inhibitors |
| EP0858457A1 (de) * | 1995-10-20 | 1998-08-19 | Dr. Karl Thomae GmbH | 5-gliedrige heterocyclen, diese verbindungen enthaltende arzneimittel und deren verwendung sowie verfahren zu ihrer herstellung |
| US6080767A (en) * | 1996-01-02 | 2000-06-27 | Aventis Pharmaceuticals Products Inc. | Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides |
| AR012443A1 (es) * | 1997-04-16 | 2000-10-18 | Uriach & Cia Sa J | Nuevas carboxamidas como inhibidores de la agregacion plaquetaria, procedimiento para su preparacion, composiciones farmaceuticas que loscontienen y uso de los mismos en la manufactura de medicamentos |
| MX2008002061A (es) * | 2005-08-18 | 2008-04-16 | Hoffmann La Roche | Derivados de tiazolil piperidina utiles como moduladores del receptor h3. |
-
2002
- 2002-12-24 GB GBGB0230162.0A patent/GB0230162D0/en not_active Ceased
-
2003
- 2003-12-24 AU AU2003290335A patent/AU2003290335A1/en not_active Abandoned
- 2003-12-24 JP JP2004563361A patent/JP2006513202A/ja active Pending
- 2003-12-24 US US10/540,645 patent/US20060135501A1/en not_active Abandoned
- 2003-12-24 CA CA002511506A patent/CA2511506A1/en not_active Abandoned
- 2003-12-24 DE DE60315355T patent/DE60315355T2/de not_active Expired - Fee Related
- 2003-12-24 EP EP03789563A patent/EP1581528B1/en not_active Expired - Lifetime
- 2003-12-24 AU AU2003294143A patent/AU2003294143A1/en not_active Abandoned
- 2003-12-24 WO PCT/GB2003/005651 patent/WO2004058750A1/en not_active Ceased
- 2003-12-24 WO PCT/GB2003/005654 patent/WO2004058751A1/en not_active Ceased
- 2003-12-24 AT AT03789563T patent/ATE368662T1/de not_active IP Right Cessation
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006513202A5 (https=) | ||
| JP2016512825A5 (https=) | ||
| RU2002123350A (ru) | Дипептиднитрильные ингибиторы катепсина К | |
| JP2020521740A5 (https=) | ||
| RU2005139524A (ru) | Ингибиторы гфат | |
| RU2011105151A (ru) | Азольные соединения | |
| WO2008028903A2 (en) | Pharmaceutical combinations of a nicotine receptor modulator and a cognitive enhancer | |
| JP2005508923A5 (https=) | ||
| RU2009125019A (ru) | Производные карбоновой кислоты | |
| JP2005524628A5 (https=) | ||
| JP2007513957A5 (https=) | ||
| RU2003114752A (ru) | Лечение желудочно-кишечных стромальных опухолей | |
| RU2008120850A (ru) | Соединения и композиции в качестве ингибиторов протеинкиназ | |
| JP2016534124A5 (https=) | ||
| JP2006514611A5 (https=) | ||
| JP2013506674A5 (https=) | ||
| RU2015104962A (ru) | Ди- и тригетероарильные производные в качестве ингибиторов агрегации белков | |
| JP2009532438A5 (https=) | ||
| RU2004119963A (ru) | Ингибиторы вич интегразы | |
| JP2009511450A5 (https=) | ||
| JP2020500192A5 (https=) | ||
| JP2008535803A5 (https=) | ||
| JP2004524279A5 (https=) | ||
| RU2003130635A (ru) | Применение производных n-фенил-2-пиримидинамина против основывающихся на мастоцитах заболевания, подобных аллергическим нарушениям | |
| JP2009501745A5 (https=) |